Figures & data
Figure 1 Appearance of subretinal bleb containing palucorcel injection immediately after completion of the injection of the cellular product at the time of surgery.
![Figure 1 Appearance of subretinal bleb containing palucorcel injection immediately after completion of the injection of the cellular product at the time of surgery.](/cms/asset/cea8b7be-9749-44da-8db5-2831eb0726b4/doph_a_140218_f0001_c.jpg)
Figure 2 Fundus photographs of the subject’s eye (A, B) before the procedure and (C, D) at 5 weeks after surgery.a
![Figure 2 Fundus photographs of the subject’s eye (A, B) before the procedure and (C, D) at 5 weeks after surgery.a](/cms/asset/ad9d2835-5bc6-4fc6-b8ae-b563ba5c0eff/doph_a_140218_f0002_c.jpg)
Figure 3 Epiretinal membrane immunocytochemistry analysis using (A, B) a combination of anti-vimentin (green), anti-neurofilament (red), ricin (blue), and Hoescht (white) and (C, D) a combination of anti-vimentin (green), anti-ezrin (red), ricin (blue), and Hoescht (white).
![Figure 3 Epiretinal membrane immunocytochemistry analysis using (A, B) a combination of anti-vimentin (green), anti-neurofilament (red), ricin (blue), and Hoescht (white) and (C, D) a combination of anti-vimentin (green), anti-ezrin (red), ricin (blue), and Hoescht (white).](/cms/asset/338fab95-7d89-4bf4-a6bb-ed54853c5698/doph_a_140218_f0003_c.jpg)
Figure 4 Epiretinal membrane immunocytochemistry analysis using (A, B) a combination of anti-vimentin (green), anti-GFAP (red), ricin (blue), and Hoescht (white) and (C, D) a combination of anti-vimentin (green), anti-Mib1 (red), ricin (blue), and Hoescht (white).
![Figure 4 Epiretinal membrane immunocytochemistry analysis using (A, B) a combination of anti-vimentin (green), anti-GFAP (red), ricin (blue), and Hoescht (white) and (C, D) a combination of anti-vimentin (green), anti-Mib1 (red), ricin (blue), and Hoescht (white).](/cms/asset/81a0ff3e-7d39-47f3-84eb-3f8c8384abb5/doph_a_140218_f0004_c.jpg)